When autoimmunity targets the lung
DAY 3
Chaired by: Dr Katie Ward (London) and Dr Rahul Mahida (Birmingham)
9:00am - Mechanisms of autoimmunity in ILD
Professor Joanna Porter (London
9:30am - Navigating the spectrum of vasculitis in ILD
Professor David Jayne (Cambridge)
10:00am - Phenotyping the myositis patient and tailoring management to specific subtypes
Dr Harsha Gunawardena (Bristol)
9:00 AM
90 MINUTE SESSION
Learning objectives
- Understand range of vasculopathy in systemic sclerosis and novel targets.
- Spectrum of vasculitis of lung and key management principals, including newer treatments on the horizon.
- To understand how clinical phenotypes may alter disease outcomes and enable tailored treatment in myositis-spectrum lung disease.
Speakers
i
BIOGRAPHY
Dr Harsha Gunawardena (MBChB MRCP UK PhD), is a Consultant Rheumatologist and Divisional Clinical Director Neurosciences and Musculoskeletal sciences Division at North Bristol NHS Trust. He co-runs a dedicated CTD vasculitis service alongside the Bristol-Interstitial Lung Disease regional service. He has a clinical academic interest in all aspects of CTD and vasculitis, in particular myositis, CTD-ILD and vasculitis. His PhD was on myositis syndromes and this work was the first to describe several novel autoantibody markers. He has published on myositis overlap syndromes, autoantibodies, CTD-ILD reviews and guidelines. He is a lead member of UK Myositis network, Myositis UK patient charity scientific committee, and on the British Society of Rheumatology Myositis and ILD Guidelines Group.
Dr Harsha Gunawardena